Many clinical trials to test the use of psychedelic medicines for conditions such as depression have been underway since 2022 - with surprising results
Related stories
An 'influencer' degree? Colleges bet on content creator major as critics question its value
EU cities plan to compensate for a fifth of their emissions through carbon removal, but few have thought through how
Monsoon-driven wildfires may have shaped human evolution
Why do people ask so few questions in conversation?
Hidden moth population found after 70 years
From toxic blooms to dead zones, how wildfires transform oceans and lakes